WIRED report exposes polarisation in long Covid research and treatment debate
A June 2026 analysis highlights the deep divide between mainstream biomedical views and mind-body therapies, revealing how operational hurdles and intimidation are stalling progress in understanding the condition.
A WIRED article published on 1 June 2026 has intensified the debate surrounding long Covid treatment and scientific methodology, highlighting a stark polarisation within the medical community. The report contrasts mainstream biomedical perspectives, which emphasise biological causes and caution against physical exercise, with mind-body therapies such as brain retraining, which some patients report have facilitated significant recovery. The analysis argues that while patient advocacy has successfully legitimised long Covid as a genuine condition, it has inadvertently fostered a climate of fear that discourages impartial scientific inquiry into psychological factors and alternative treatments.
The piece details specific case studies, including Andrew Larson, a 37-year-old researcher who recovered from severe long Covid symptoms through brain retraining with Dr Becca Kennedy, and Giorgia Lupi, an information designer who faced backlash from advocacy groups after crediting mind-body interventions for her recovery. New insights are provided into the operational challenges for researchers, such as Institutional Review Boards in the United States refusing to approve exercise trials due to perceived ethical risks, and the intimidation tactics faced by researchers like Paul Garner and Michael Donnino.
The article highlights the 2024 National Academies of Sciences, Engineering, and Medicine definition of long Covid as "intentionally inclusive," which has been criticised by experts like Adam Gaffney for being too broad to be scientifically useful. It reports on Michael Donnino’s pilot study at Harvard Medical School, which showed promising results for Sarno-inspired brain retraining for long Covid, and his subsequent move to a randomised controlled trial.
The report underscores the historical context of this conflict, drawing parallels to the debate over myalgic encephalitis/chronic fatigue syndrome. It notes that the legacy of controversial studies, such as the PACE trial, has led to a strong aversion to exercise in patient communities and a rigid adherence to biological explanations. This environment has made it difficult for researchers to explore the potential role of the nervous system in symptom persistence, with many fearing professional retaliation or harassment for suggesting psychological components to the illness.
Ultimately, the article suggests that the current scientific impasse is driven by cultural and philosophical issues rather than purely clinical evidence. It argues that the binary distinction between "biological" and "psychological" causes is flawed, as the brain is a biological organ that can influence physical symptoms. The piece concludes that until the scientific community can investigate these possibilities without fear of reprisal, patients will continue to suffer from a lack of effective, evidence-based treatments.
